Filing Details
- Accession Number:
- 0001179110-21-003143
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-09 17:44:45
- Reporting Period:
- 2021-03-05
- Accepted Time:
- 2021-03-09 17:44:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1477449 | Teladoc Health Inc. | TDOC | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1208500 | N Jason Gorevic | C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-03-05 | 20,220 | $183.18 | 548,296 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-03-05 | 8,190 | $12.21 | 556,486 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-03-05 | 4,484 | $22.30 | 560,970 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-03-05 | 8,190 | $0.00 | 8,190 | $12.21 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-03-05 | 4,484 | $0.00 | 4,484 | $22.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
383,649 | 2026-03-07 | No | 4 | M | Direct | |
400,116 | 2027-03-03 | No | 4 | M | Direct |
Footnotes
- Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards.
- The option vested as to 25% of the shares on March 7, 2017. The remainder of the shares vested in 36 equal monthly installments thereafter.
- The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vested in 36 equal monthly installments thereafter.